{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:47:47Z","timestamp":1777888067314,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.7759\/cureus.108071","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:34:02Z","timestamp":1777610042000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Approaches to Carbapenemase Detection in Pseudomonas aeruginosa: A Comparative Review of Phenotypic and Genotypic Methods"],"prefix":"10.7759","author":[{"given":"Bhaskar Y","family":"Chavali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha V","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish R","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1347521","article-title":"Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime\/avibactam and ceftolozane\/tazobactam in a tertiary care university hospital center in Portugal - a cross-sectional and retrospective observational study","volume":"15","author":"Pedro DM","year":"2024","unstructured":"Pedro DM, Paulo SE, Santos CM, Fonseca AB, Cristino JM, Pereira \u00c1A, Caneiras C. Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime\/avibactam and ceftolozane\/tazobactam in a tertiary care university hospital center in Portugal - a cross-sectional and retrospective observational study. Front Microbiol. 2024, 15:10.3389\/fmicb.2024.1347521","journal-title":"Front Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00233-24","article-title":"Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa","volume":"38","author":"Horcajada JP","year":"2025","unstructured":"Horcajada JP, Gales AC, Isler B, et al.. Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa. Clin Microbiol Rev. 2025, 38:10.1128\/cmr.00233-24","journal-title":"Clin Microbiol Rev"},{"key":"ref3","unstructured":"Antimicrobial Resistance Laboratory Network. (2026). https.\/\/www.cdc.gov\/antimicrobial-resistance-laboratory-networks\/php\/about\/domestic.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268825100332","article-title":"Worldwide threatening prevalence of carbapenem-resistant Pseudomonas aeruginosa","volume":"153","author":"Ahmadi MH","year":"2025","unstructured":"Ahmadi MH, Aghmiyuni ZF, Bakhti S. Worldwide threatening prevalence of carbapenem-resistant Pseudomonas aeruginosa. Epidemiol Infect. 2025, 153:10.1017\/S0950268825100332","journal-title":"Epidemiol Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf249","article-title":"An improved algorithm to screen for carbapenemase production in Pseudomonas aeruginosa","volume":"8","author":"Ellem JA","year":"2026","unstructured":"Ellem JA, Brown MJ, Sandaradura I, McSharry BP, Vanniasinkam T. An improved algorithm to screen for carbapenemase production in Pseudomonas aeruginosa. JAC Antimicrob Resist. 2026, 8:10.1093\/jacamr\/dlaf249","journal-title":"JAC Antimicrob Resist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02874-20","article-title":"Antimicrobial susceptibility profiles to predict the presence of carbapenemase genes among carbapenem-resistant Pseudomonas aeruginosa isolates","volume":"59","author":"Vallabhaneni S","year":"2021","unstructured":"Vallabhaneni S, Huang JY, Grass JE, et al.. Antimicrobial susceptibility profiles to predict the presence of carbapenemase genes among carbapenem-resistant Pseudomonas aeruginosa isolates. J Clin Microbiol. 2021, 59:10.1128\/JCM.02874-20","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01369-17","article-title":"Multicenter evaluation of the modified carbapenem inactivation method and the Carba NP for detection of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"56","author":"Simner PJ","year":"2017","unstructured":"Simner PJ, Johnson JK, Brasso WB, et al.. Multicenter evaluation of the modified carbapenem inactivation method and the Carba NP for detection of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. J Clin Microbiol. 2017, 56:10.1128\/JCM.01369-17","journal-title":"J Clin Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2048972","article-title":"Carbapenemase-producing Pseudomonas aeruginosa - an emerging challenge","volume":"11","author":"Tenover FC","year":"2022","unstructured":"Tenover FC, Nicolau DP, Gill CM. Carbapenemase-producing Pseudomonas aeruginosa - an emerging challenge. Emerg Microbes Infect. 2022, 11:811-4. 10.1080\/22221751.2022.2048972","journal-title":"Emerg Microbes Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00122-22","article-title":"Evaluation of the performance and clinical impact of a rapid phenotypic susceptibility testing method directly from positive blood culture at a pediatric hospital","volume":"60","author":"Truong TT","year":"2022","unstructured":"Truong TT, Mongkolrattanothai K, Flores II, Bard JD. Evaluation of the performance and clinical impact of a rapid phenotypic susceptibility testing method directly from positive blood culture at a pediatric hospital. J Clin Microbiol. 2022, 60:10.1128\/jcm.00122-22","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1599070","article-title":"Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis","volume":"16","author":"Ramatla T","year":"2025","unstructured":"Ramatla T, Nkhebenyane J, Lekota KE, Thekisoe O, Monyama M, Achilonu CC, Khasapane G. Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis. Front Microbiol. 2025, 16:10.3389\/fmicb.2025.1599070","journal-title":"Front Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/JLP.JLP_136_19","article-title":"Detection of carbapenemase-producing Pseudomonas aeruginosa by phenotypic and genotypic methods in a tertiary care hospital of East India","volume":"11","author":"Verma N","year":"2019","unstructured":"Verma N, Prahraj AK, Mishra B, Behera B, Gupta K. Detection of carbapenemase-producing Pseudomonas aeruginosa by phenotypic and genotypic methods in a tertiary care hospital of East India. J Lab Physicians. 2019, 11:287-91. 10.4103\/JLP.JLP_136_19","journal-title":"J Lab Physicians"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2022.43.3.20210809","article-title":"Phenotypic and genotypic detection of carbapenemase production among Gram negative bacteria isolated from hospital acquired infections","volume":"43","author":"Vamsi SK","year":"2022","unstructured":"Vamsi SK, Moorthy RS, Hemiliamma MN, Chanderakant DJ, Sirikonda S. Phenotypic and genotypic detection of carbapenemase production among Gram negative bacteria isolated from hospital acquired infections. Saudi Med J. 2022, 43:236-43. 10.15537\/smj.2022.43.3.20210809","journal-title":"Saudi Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4314\/ajhs.v37i4.6","article-title":"Carbapenem resistance among Pseudomonas aeruginosa isolated from clinical samples with a special reference to colistin resistance","volume":"37","author":"Rajendran R","year":"2025","unstructured":"Rajendran R, Thulichery BN, Divakaran D, Bijapur GA. Carbapenem resistance among Pseudomonas aeruginosa isolated from clinical samples with a special reference to colistin resistance. Afr J Health Sci. 2025, 37:432-40. 10.4314\/ajhs.v37i4.6","journal-title":"Afr J Health Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.100797","article-title":"Changing battlelines: 12-month antimicrobial resistance trends at a tertiary care hospital in Nagpur, Maharashtra, India","volume":"18","author":"Mohod SV","year":"2026","unstructured":"Mohod SV, Rajan A, Asokan D, Das P, Agrawal G. Changing battlelines: 12-month antimicrobial resistance trends at a tertiary care hospital in Nagpur, Maharashtra, India. Cureus. 2026, 18:10.7759\/cureus.100797","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20250967","article-title":"Study of carbapenem resistance in patients admitted to MICU in a tertiary care hospital","volume":"13","author":"Shaji EP","year":"2025","unstructured":"Shaji EP, Iravane JA, Harbade MS, Gaikwad AA. Study of carbapenem resistance in patients admitted to MICU in a tertiary care hospital. Int J Res Med Sci. 2025, 13:1472-6. 10.18203\/2320-6012.ijrms20250967","journal-title":"Int J Res Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01140-18","article-title":"Phenotypic detection of carbapenemase-producing organisms from clinical isolates","volume":"56","author":"Tamma PD","year":"2018","unstructured":"Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018, 56:10.1128\/JCM.01140-18","journal-title":"J Clin Microbiol"},{"key":"ref17","article-title":"CLSI M100: Performance Standards for Antimicrobial Susceptibility Testing. Thirty-sixth Edition","year":"2026","unstructured":"CLSI M100. Performance Standards for Antimicrobial Susceptibility Testing. Thirty-sixth Edition. Mathers AJ, Lewis JS, Bryson AL, et al. (ed): Clinical and Laboratory Standards Institute, Wayne, PA; 2026."},{"key":"ref18","article-title":"CLSI M100: Performance Standards for Antimicrobial Susceptibility Testing. Thirty-third Edition","year":"2023","unstructured":"CLSI M100. Performance Standards for Antimicrobial Susceptibility Testing. Thirty-third Edition. Clinical and Laboratory Standards Institute, Wayne, PA; 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.120355","article-title":"Rapid detection of carbapenemase-producing Enterobacteriaceae","volume":"18","author":"Nordmann P","year":"2012","unstructured":"Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012, 18:1503-7. 10.3201\/eid1809.120355","journal-title":"Emerg Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01597-12","article-title":"Rapid detection of carbapenemase-producing Pseudomonas spp","volume":"50","author":"Dortet L","year":"2012","unstructured":"Dortet L, Poirel L, Nordmann P. Rapid detection of carbapenemase-producing Pseudomonas spp. J Clin Microbiol. 2012, 50:3773-6. 10.1128\/JCM.01597-12","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123690","article-title":"The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods","volume":"10","author":"van der Zwaluw K","year":"2015","unstructured":"van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. PLoS One. 2015, 10:10.1371\/journal.pone.0123690","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01734-10","article-title":"Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples","volume":"55","author":"Naas T","year":"2011","unstructured":"Naas T, Ergani A, Carr\u00ebr A, Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother. 2011, 55:4038-43. 10.1128\/AAC.01734-10","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02761-13","article-title":"Evaluation of the Carba NP test for carbapenemase detection","volume":"58","author":"Osterblad M","year":"2014","unstructured":"Osterblad M, Hakanen AJ, Jalava J. Evaluation of the Carba NP test for carbapenemase detection. Antimicrob Agents Chemother. 2014, 58:7553-6. 10.1128\/AAC.02761-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tree.2015.03.009","article-title":"Measurably evolving pathogens in the genomic era","volume":"30","author":"Biek R","year":"2015","unstructured":"Biek R, Pybus OG, Lloyd-Smith JO, Didelot X. Measurably evolving pathogens in the genomic era. Trends Ecol Evol. 2015, 30:306-13. 10.1016\/j.tree.2015.03.009","journal-title":"Trends Ecol Evol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-022-00857-4","article-title":"Evaluation of phenotypic detection of carbapenemase-producing Pseudomonas spp. from clinical isolates","volume":"54","author":"Santos IC","year":"2023","unstructured":"Santos IC, Neto OC, da Costa BS, et al.. Evaluation of phenotypic detection of carbapenemase-producing Pseudomonas spp. from clinical isolates. Braz J Microbiol. 2023, 54:135-41. 10.1007\/s42770-022-00857-4","journal-title":"Braz J Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1357289","article-title":"Molecular characteristics and evaluation of the phenotypic detection of carbapenemases among Enterobacterales and Pseudomonas via whole genome sequencing","volume":"14","author":"Liang B","year":"2024","unstructured":"Liang B, Chen Y, Liang Z, et al.. Molecular characteristics and evaluation of the phenotypic detection of carbapenemases among Enterobacterales and Pseudomonas via whole genome sequencing. Front Cell Infect Microbiol. 2024, 14:10.3389\/fcimb.2024.1357289","journal-title":"Front Cell Infect Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116370","article-title":"Carbapenemase producing Gram negative bacteria: review of resistance and detection methods","volume":"110","author":"Paudel R","year":"2024","unstructured":"Paudel R, Shrestha E, Chapagain B, Tiwari BR. Carbapenemase producing Gram negative bacteria: review of resistance and detection methods. Diagn Microbiol Infect Dis. 2024, 110:10.1016\/j.diagmicrobio.2024.116370","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/482737-diagnostic-approaches-to-carbapenemase-detection-in-pseudomonas-aeruginosa-a-comparative-review-of-phenotypic-and-genotypic-methods","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:34:11Z","timestamp":1777610051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/482737-diagnostic-approaches-to-carbapenemase-detection-in-pseudomonas-aeruginosa-a-comparative-review-of-phenotypic-and-genotypic-methods"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.108071","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}